Effect of iron supplementation on erythropoiesis and iron-related parameters in hemodialysis patients receiving epoetin beta pegol: a randomized controlled study
Not Applicable
- Conditions
- Patients treated with maintenance hemodialysis
- Registration Number
- JPRN-UMIN000010084
- Lead Sponsor
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with chronic inflammation, malignant disorder, severe congestive heart failure, respiratory organs, and liver disorder (2) Patients who are receiving dialysis modalities other than hemodialysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Hemoglobin and erythropoiesis-related indexes (2)Blood chemical examination including iron-related, inflammation, nutrition indexes (3)Required dose of epoetin beta pegol (4)Hemodynamic parameters
- Secondary Outcome Measures
Name Time Method